Exponent (NASDAQ:EXPO) had its price objective increased by Cantor Fitzgerald from $64.00 to $73.00 in a research report sent to investors on Friday morning, The Fly reports. Cantor Fitzgerald currently has an overweight rating on the business services provider’s stock. Cantor Fitzgerald also issued estimates for Exponent’s FY2019 earnings at $1.49 EPS and FY2020 earnings at $1.63 EPS.
Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Golub Capital BDC from a hold rating to a buy rating and set a $20.00 price target on the stock in a research note on Tuesday, July 16th. William Blair reaffirmed a market perform rating on shares of W W Grainger in a research note on Monday, April 22nd. Finally, BidaskClub downgraded shares of Ames National from a hold rating to a sell rating in a research note on Wednesday, July 17th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $74.50.
Shares of EXPO stock opened at $66.87 on Friday. The company has a fifty day simple moving average of $59.30. Exponent has a 52 week low of $44.44 and a 52 week high of $68.12. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.22 and a current ratio of 3.60. The stock has a market cap of $3.45 billion, a P/E ratio of 53.50 and a beta of 0.44.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Thursday, September 5th. Exponent’s dividend payout ratio (DPR) is 51.20%.
In related news, Director Carol Lindstrom sold 1,800 shares of Exponent stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $56.92, for a total transaction of $102,456.00. Following the sale, the director now owns 3,212 shares of the company’s stock, valued at approximately $182,827.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.30% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in EXPO. Cim LLC acquired a new position in Exponent during the 2nd quarter valued at about $200,000. Bessemer Group Inc. acquired a new position in Exponent during the 2nd quarter valued at about $2,986,000. We Are One Seven LLC boosted its stake in Exponent by 63.1% during the 2nd quarter. We Are One Seven LLC now owns 7,785 shares of the business services provider’s stock valued at $455,000 after purchasing an additional 3,012 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in Exponent by 2.0% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,544 shares of the business services provider’s stock valued at $1,203,000 after purchasing an additional 400 shares during the period. Finally, NN Investment Partners Holdings N.V. acquired a new position in Exponent during the 2nd quarter valued at about $91,000. 88.51% of the stock is currently owned by hedge funds and other institutional investors.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Read More: What is Depreciation?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.